GL1X · GenesisL1 explorer

Research workbench

The kinase domain of human lymphocyte kinase (lck), activated form (auto-phosphorylated on TYR394)

Analyse The kinase domain of human lymphocyte kinase (lck), activated form… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3LCK
Type
protein
Length
271 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proto-oncogene tyrosine-protein kinase
EC
2.7.1.112
UniProt
P06239
Ligands
SO4
Pockets
2 · best druggability 0.60

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProto-oncogene tyrosine-protein kinase (EC 2.7.1.112)protein27138% helix, 20% strandP06239

Ligands and binding sites

  • SO4 · Sulfate ion · ion · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13340.600.7736empty
2500.320.7713empty

Modifications

Observed in the structure: 1 modified (phosphorylation).

Compared structures

  • 3LCK · The kinase domain of human lymphocyte kinase (lck), activated form (auto-phosphorylated… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.